LENSAR, Inc.LNSR

$5.74-0.52 (-8.31%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$89M
Micro-cap
+30%
2020 — today
10-Year Price
-37%
2020 — today
52-Week Range
$5.09$13.32
Current $5.74· 8%

LENSAR, Inc. is an established medical device company that specializes in the development and commercialization of an advanced femtosecond laser system. This innovative technology is designed for the surgical treatment of cataracts and the precise management of corneal astigmatism, regardless of whether it's pre-existing or a consequence of surgery. The core of their offering, the LENSAR Laser System, incorporates a suite of exclusive technologies. These are specifically engineered to empower surgeons, enhancing surgical precision, optimizing patient visual results, and ensuring both operational efficiency and consistent procedural outcomes. This is achieved through its sophisticated capabilities in imaging, comprehensive procedure planning, adaptable design features, and unparalleled accuracy. Established in 2004, LENSAR, Inc. is headquartered in Orlando, Florida.

Valuation in context

P/E ratio
-9.9
N/A
Not meaningful — company is unprofitable
P/B ratio
3.6
Near historic high
Near historic highs — last 10 years
EV / EBITDA
2.3
Below average
Below the 10-year average
FCF Yield
-13.8%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when LNSR is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.